|Bid||44.78 x 1200|
|Ask||44.86 x 1200|
|Day's Range||43.55 - 45.11|
|52 Week Range||33.33 - 64.49|
|Beta (5Y Monthly)||1.23|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 20, 2023 - Feb 24, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||60.56|
Subscribe to Yahoo Finance Plus to view Fair Value for GKOS
Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Glaukos Corporation ( NYSE:GKOS ) shareholders have seen the share price descend 16% over the month. On the bright side...
Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.